MIM
THRX

MetLife Investment Management’s Theseus Pharmaceuticals, Inc. Common Stock THRX Stock Holding History

MetLife Investment Management’s Portfolio THRX Stock Details THRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-10,330
Closed -$96.4K – 3001
2023
Q2 		$96.4K Hold
10,330
– – ﹤0.01% 2702
2023
Q1 		$91.7K Buy
+10,330
New +$91.7K ﹤0.01% 2589